Industry News

Medical Device Industry News

MOWOOT earns FDA’s First-Ever ‘Breakthrough Device Designation’ for a Novel Non-Drug and Non-Invasive Therapy of Neurogenic Bowel Disorder

December 17th, 2021|Medical Device News Magazine|

"The Breakthrough Device Designation is a significant milestone for our company and validates our belief that our solution offers significant advantages over existing approved or cleared alternatives, per FDA requirements." said Dr. Markus Wilhelms, CEO

MOWOOT earns FDA’s First-Ever ‘Breakthrough Device Designation’ for a Novel Non-Drug and Non-Invasive Therapy of Neurogenic Bowel Disorder

December 17th, 2021|Medical Device News Magazine|

"The Breakthrough Device Designation is a significant milestone for our company and validates our belief that our solution offers significant advantages over existing approved or cleared alternatives, per FDA requirements." said Dr. Markus Wilhelms, CEO